Literature DB >> 30112257

Takayasu Arteritis: A Diagnosis Made Using a Multidisciplinary Approach.

Quratulain Fatima Masood1, Anika Naeem2, Syed Maaz Tariq3, Ali Asad4, Sara Habib5.   

Abstract

Takayasu arteritis is an idiopathic chronic vasculitis that involves large blood vessels, including the aorta and its main branches. This disease presents typically as ischemia or aneurysms that could be prevented by timely diagnosis and vigilant management. We present here the case of a 19-year-old male who presented with a history of visual disturbance, chest pain, dizziness, and a feeble pulse.

Entities:  

Keywords:  arteritis; stenosis; takayasu

Year:  2018        PMID: 30112257      PMCID: PMC6089487          DOI: 10.7759/cureus.2781

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  5 in total

1.  What is new in management of Takayasu arteritis?

Authors:  Gokhan Keser; Kenan Aksu
Journal:  Presse Med       Date:  2017-07-31       Impact factor: 1.228

2.  Open and Endovascular Management of Severe Cerebral Ischemia in Takayasu's Arteritis.

Authors:  Xiao Yun Luo; Qing Hua Wu; Fu Xian Zhang
Journal:  Ann Vasc Surg       Date:  2017-03-01       Impact factor: 1.466

3.  Cerebrovascular events in Takayasu arteritis: a multicenter case-controlled study.

Authors:  Priscille Couture; Thibaud Chazal; Charlotte Rosso; Julien Haroche; Anne Léger; Baptiste Hervier; Sandrine Deltour; Zahir Amoura; Fleur Cohen Aubart
Journal:  J Neurol       Date:  2018-02-01       Impact factor: 4.849

4.  Aorto-carotid bypass in patients with Takayasu arteritis.

Authors:  Hong Seok Han; Kyoung Won Yoon; Seon-Hee Heo; Yang Jin Park; Young-Wook Kim; Dong-Ik Kim
Journal:  Ann Surg Treat Res       Date:  2017-08-30       Impact factor: 1.859

5.  Takayasu Arteritis With Antiphosphatidylserine/Prothrombin Antibody-Positive Antiphospholipid Syndrome: Case Report and Literature Review.

Authors:  Shoichi Fukui; Shogo Hirota; Naoki Iwamoto; Hiroki Karata; Atsushi Kawakami
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.